Cohen Klingenstein LLC

SEC CIK: 0001453620
Latest filing: Jul 15, 2026

SEC filings (opens in a new tab)

GSK holding history

GSK plc in every 13F filed by Cohen Klingenstein LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overview All 13F holders of GSK Full Q2 2026 holdings

Shares (Q2 2026): 79,398
Value: $4.16M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of GSK by Cohen Klingenstein LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	79,398	$4.16M	0.1%	00.0%	Unchanged	Holders
Q1 2026	79,398	$4.38M	0.1%	00.0%	Unchanged	Holders
Q4 2025	79,398	$3.89M	0.1%	00.0%	Unchanged	Holders
Q3 2025	79,398	$3.43M	0.1%	00.0%	Unchanged	Holders
Q2 2025	79,398	$3.05M	0.1%	00.0%	Unchanged	Holders
Q1 2025	79,398	$3.08M	0.1%	−18,800−19.1%	Reduced	Holders
Q4 2024	98,198	$3.32M	0.1%	−6,114−5.9%	Reduced	Holders
Q3 2024	104,312	$4.26M	0.1%	−828−0.8%	Reduced	Holders
Q2 2024	105,140	$4.05M	0.1%	−13,200−11.2%	Reduced	Holders
Q1 2024	118,340	$5.07M	0.2%	−5,600−4.5%	Reduced	Holders
Q4 2023	123,940	$4.59M	0.2%	−8,400−6.3%	Reduced	Holders
Q3 2023	132,340	$4.80M	0.2%	−16,000−10.8%	Reduced	Holders
Q2 2023	148,340	$5.29M	0.2%	00.0%	Unchanged	Holders
Q1 2023	148,340	$5.28M	0.2%	00.0%	Unchanged	Holders
Q4 2022	148,340	$5.21M	0.3%	−20,851−12.3%	Reduced	Holders
Q3 2022	169,191	$4.98M	0.3%	−42,309−20.0%	Reduced	Holders
Q2 2022	211,500	$9.21M	0.5%	00.0%	Unchanged	Holders
Q1 2022	211,500	$9.21M	0.4%	00.0%	Unchanged	Holders
Q4 2021	211,500	$9.33M	0.4%	−50,000−19.1%	Reduced	Holders
Q3 2021	261,500	$9.99M	0.4%	−7,230−2.7%	Reduced	Holders
Q2 2021	268,730	$10.7M	0.5%	00.0%	Unchanged	Holders
Q1 2021	268,730	$9.59M	0.4%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.